The protective effect of the active components of ERPC on diabetic peripheral neuropathy in rats

Publication date: 18 April 2017
Source:Journal of Ethnopharmacology, Volume 202
Author(s): Gai-mei Hao, Yong-gang Liu, Yan Wu, Wei Xing, Shu-zhen Guo, Yong Wang, Zheng-lin Wang, Chun Li, Tian-tian Lv, Hong-liang Wang, Tian-jiao Shi, Wei Wang, Jing Han
Ethnopharmacological relevanceEuonymus alatus, Radix trichosanthis, Panax notoginseng and Coptis chinensis are popular plants used in traditional Chinese medicine to treat diabetes.Aim of the studyThe aim of the study is to investigate the therapeutic effect of the active components of Euonymus alatus, Radix trichosanthis, Panax notoginseng and Coptis chinensis (cERPC) on diabetic peripheral neuropathy in the rats and explore the underlying mechanism involved.MethodsAfter diabetes was induced in rats for 20 weeks, cERPC or water was administered for 12 weeks. After a hot plate test, motor nerve conduction velocity and sciatic nerve blood flow were determined; the sciatic nerves were isolated for toluidine blue staining; and the fibre area, fibre diameter, axon area, axon diameter and myelin thickness were evaluated. The levels of the myelin basic protein, myelin protein zero, Oct6 and Krox20 were measured by western blot or immunofluorescence.ResultscERPC was efficient in reducing the response latency, increasing motor nerve conduction velocity, enhancing sciatic nerve blood flow and ameliorating the pathological changes in diabetic rats. cERPC also had a role in increasing the levels of myelin basic protein and myelin protein zero and improving the expression of Oct6 and Krox20 in sciatic nerves of diabetic rats.ConclusionscERPC ameliorates diabetic peripheral neuropathy by attenuating electrophysiological, circulatory and morphological alterations, which is mediated by the Oct6-Krox20 pathway.

Graphical abstract

http://ift.tt/2nNt26a